Loading...
NPI 1235121450 · Cedar Rapids, IA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Weland Clinical Laboratories, P.C. is a clinical medical laboratory provider located in Cedar Rapids, Iowa. This profile covers 160 Medicare and 102 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Weland Clinical Laboratories, P.C. |
| Address | 1911 1st Ave Se |
| City | Cedar Rapids |
| State | IA |
| ZIP | 52402 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | August 16, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $3.8M |
| Medicare | $1.2M |
WELAND CLINICAL LABORATORIES, P.C. is a clinical medical laboratory with an NPI enumerated ~21 years ago (2005-08-16), indicating long-term presence in the market and established billing relationships across public payers. The code mix — heavy representation of surgical pathology (e.g., 88305, 88307, 88341/88342) alongside high-volume specimen collection and routine chemistries — is consistent with a lab that performs both anatomic pathology and high-throughput clinical testing.
Medicaid is the larger payer relationship by scale: total Medicaid revenue is $3.8M versus total Medicare revenue of $1.2M, indicating the provider’s operations generate more revenue from state programs than from Medicare. This payer mix suggests reliance on Medicaid volume for overall financial throughput and possibly extensive participation in state public-health testing programs.
Revenue concentration is high on both payers for a small set of codes. Precomputed metrics show the top 3 Medicare codes account for 55.2% of Medicare revenue and the top 3 Medicaid codes account for 51.7% of Medicaid revenue, indicating that a few services (notably 88305 and related pathology codes) drive the majority of public-payer receipts. Such concentration highlights that shifts in reimbursement or referral patterns for those specific services would materially affect total revenue.
88305 is the dominant code across both payers: it represents $398.8K (41.0% of Medicare revenue) for Medicare and $1.2M (36.6% of Medicaid revenue) for Medicaid. Nationally and in-state rankings are very high (Medicare rank #144 of 14,580 at the 99th percentile; Medicaid rank #4 of 94 in-state at the 97th percentile), so the practice is a major regional provider of surgical pathology services and an outlier in volume relative to peers. This suggests a specialty emphasis on surgical pathology that likely attracts specimens from a wide referral network.
Several pathology codes show extreme or notable outlier status on Medicare, underscoring concentrated expertise: 88305 ranks at the 99th percentile as an "extreme outlier, far above typical national volume for this code," and other pathology-related codes such as 88307 (rank #26 of 8,511; 100th percentile) and 88331 (rank #39 of 4,659; 99th percentile) are likewise characterized as extreme outliers. These rank descriptors signal that the provider handles unusually large volumes of higher-complexity pathology reviews compared with national peers.
The Medicaid top-code profile reinforces strong cytology and STI/STD testing volume in-state: 88175 (cytopathology screening) ranks #2 of 15 in-state and 87624 (HPV testing) ranks #2 of 17 in-state, both described as above-typical state volume. Additionally, a set of nucleic-acid and direct probe tests for sexually transmitted infections (87491, 87591, 87510, 87660, 87480) appear among the highest Medicaid revenue lines, consistent with substantial public-health or clinic-based screening throughput.
Operationally, the lab runs both high-volume specimen collection and routine panels alongside specialized pathology. High claim counts for specimen collection and routine tests (e.g., 36415; 11.7K Medicare claims and 21.6K Medicaid claims) plus panel codes (80050, 80061, 80053) indicate significant outpatient/sample-collection business, while the disproportionate revenue share from pathology codes (88305/88307) shows a dual service-line model combining volume testing with higher-complexity anatomic pathology.
Competitive standing differs by payer scope: for Medicare the provider is an extreme national outlier on several pathology codes (high national percentile ranks), signaling above-typical national presence for those services, whereas for Medicaid the provider ranks among the top in-state performers on key codes (e.g., 88305 rank #4 in-state), indicating strong regional market position. Together, those standings point to a lab that is modestly visible nationally for select pathology services but a significant local/state player for public-payer testing.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
160 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 14,240 | $30 | $398.8K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 11,740 | $10 | $93.9K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 1,910 | $20 | $43.9K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 2,420 | $20 | $38.6K |
| 88307 | The physician, typically a pathologist, performs a level V examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 600 | $60 | $35.8K |
| 88331 | Pathological, or intraoperative, consultation provides necessary and precise information pertaining to diagnosis and prognosis which aid a surgeon in deciding whether to proceed further or not during… | 570 | $60 | $32.3K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 4,440 | $10 | $31K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 2,380 | $10 | $31K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 3,060 | $10 | $30.6K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 890 | $30 | $25K |
Showing 1–10 of 160
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 160 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
102 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 18,750 | $70 | $1.2M |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 11,710 | $20 | $257.7K |
| 88307 | The physician, typically a pathologist, performs a level V examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 3,340 | $70 | $244.1K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 6,620 | $30 | $198.5K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 3,330 | $40 | $143K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 2,780 | $50 | $141.8K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 2,770 | $30 | $94K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 2,760 | $30 | $93.8K |
| 87510 | The lab analyst performs a test for Gardnerella vaginalis using direct nucleic acid probe technique. Gardnerella vaginalis typically causes bacterial vaginosis, an infection of the vagina that… | 4,130 | $20 | $78.5K |
| 87660 | The lab analyst performs a test for Trichomonas vaginalis using direct nucleic acid probe technique. | 4,130 | $20 | $78.5K |
Showing 1–10 of 102
How this provider's Medicaid billing volume and revenue compare to other Iowa providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Iowa median
102 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87507 | The lab analyst performs a test to detect 12 to 25 types or subtypes of a pathogen, such as Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia, that affects the gastrointestinal… | 5 | 10 | 330 | $360 | $286.9K |
| 0202U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0202U for the… | 49 | 50 | 130 | $320 | $224.4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 45 | 60 | 210 | $80 | $186.8K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 4 | 90 | 740 | $60 | $155.6K |
| 88307 | The physician, typically a pathologist, performs a level V examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 5 | 20 | 130 | $80 | $107.3K |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 2 | 20 | 660 | $20 | $104.8K |
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 23 | 30 | 200 | $110 | $85.8K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 2 | 20 | 890 | $30 | $80.7K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 14 | 60 | 320 | $30 | $72.6K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 14 | 60 | 300 | $30 | $71.8K |
Showing 1–10 of 102
Other providers in the same ZIP code as Weland Clinical Laboratories, P.C., ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.